Stock Buybacks (Quarterly) Chart

View Stock Buybacks (Quarterly) for AMRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Stock Buybacks (Quarterly) Chart
Start Trial

Historical Stock Buybacks (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -0.059M
March 31, 2026 0.00
December 31, 2025 -0.0831M
September 30, 2025 0.0003M
June 30, 2025 -0.0575M
March 31, 2025 0.00
December 31, 2024 0.0015M
September 30, 2024 -0.0006M
June 30, 2024 -0.122M
March 31, 2024 -0.01M
December 31, 2023 -0.0912M
September 30, 2023 0.002M
June 30, 2023 -0.2434M
March 31, 2023 -1.888M
December 31, 2022 -0.2271M
September 30, 2022 -0.0081M
June 30, 2022 -0.3996M
March 31, 2022 -0.0298M
December 31, 2021 -0.9191M
September 30, 2021 -0.4871M
June 30, 2021 -1.098M
March 31, 2021 -2.066M
December 31, 2020 -4.450M
September 30, 2020 -0.2099M
June 30, 2020 -1.204M
Date Value
March 31, 2020 -1.307M
December 31, 2019 -7.557M
September 30, 2019 -442.89M
June 30, 2019 -2.615M
March 31, 2019 -15.62M
December 31, 2018 -204.83M
September 30, 2018 -14.88M
June 30, 2018 -0.0506M
March 31, 2018 -72.03M
December 31, 2017 -0.1887M
September 30, 2017 -0.0589M
June 30, 2017 -0.1141M
March 31, 2017 -0.2831M
December 31, 2016 -1.411M
September 30, 2016 -62.59M
June 30, 2016 0.0079M
March 31, 2016 0.6314M
December 31, 2015 -28.57M
September 30, 2015 -5.922M
June 30, 2015 -1.739M
March 31, 2015 -51.35M
December 31, 2014 0.0264M
September 30, 2014 -1.690M
June 30, 2014 0.0039M
March 31, 2014 -0.2978M

Stock Buyback Definition

Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.

Read full definition.

Stock Buybacks (Quarterly) Range, Past 5 Years

View Stock Buybacks (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Stock Buybacks (Quarterly) Benchmarks

View Stock Buybacks (Quarterly) Benchmarks
Start Trial
Neurocrine Biosciences, Inc. -128.50M
Alkermes Plc 1.485B
Cellectis SA -0.1741M
Akari Therapeutics Plc -8.237M
Liquidia Corp. -1.443M